BBI Solutions

Nobody goes to conferences to be sold to.   With ADLM around the corner we wanted to provide you something more than the usual bunch of branded pens and mugs.   That's why we're thrilled to be bringing our team of technical experts to help you tackle the real challenges you're facing in the lab, share cutting-edge developments and best practices, and help you get the most out of your time at ADLM.   During the conference you'll be able to sit down with Melissa Hamel our Antibodies and Gold Specialist, Simon Packer our Antigen specialist, Lisa Mansell our Lateral Flow specialist and Tinus de Wet - our enzymes specialist and make the most of their experience and expertise.   We expect them to get booked up very quickly, so click the link below and secure your slot early. Plus keep an eye out for a very special announcement in the coming days.   https://lnkd.in/d3xjekUs

Thank you to everyone who attended our session at Merck Point of Care Workshop 2024, and to everyone we met over the past few days. Our experts had a great time meeting with you all! If you missed us - don't worry - you can reach out anytime to see how we can support you. Simply drop us a line on LinkedIn or send us a message via our website: https://lnkd.in/ehhEjzNF

Are you attending the Merck Rapid Point of Care Workshop? Do you want to get the most out of the experience? Then book a meeting with our experts! In between delivering a special workshop on "Robustness and Scalability - Essentials for a successful transfer to manufacture" - Rob B. and Lisa Mansell will be on hand to offer their expert guidance for all things related to the development and manufacture of lateral flow tests. Spaces are limited so book soon and don't miss out! https://lnkd.in/ejFCYUTb

Are you ready to stop compromising on your blood cancer diagnostics? If you’re using native B2M, you’ll be (painfully) aware of how unreliable it can be. Because of the genetic differences in source material, and the limited supplies available, testing each batch and scaling up to meet demand can be difficult. That’s why we’ve developed recombinant B2M. All of the benefits of native, with none of the drawbacks. Unlike native, it doesn’t rely on human sources. We manufacture it using recombinant DNA technology, in bioreactors at our state-of-the-art facilities. The result is scalable, genetically identical batches of B2M with unmatched lot-to-lot consistency. It’s blood cancer diagnostics without compromise, and we’d like you to try it for yourself. Order your sample now: https://lnkd.in/ga6TJR-2

The long path to developing a new in vitro diagnostic can be rocky. But we're here to help. Join our industry leading experts Lisa Mansell and Rob B. for a special workshop on 13th June - alongside other industry leaders at Merck Life Science Rapid Point of Care Workshop 2024. The event is going to be an information-packed, three-day journey that will take you through every stage in the development and manufacture of a lateral flow test. Don't miss out! Book your seat here: https://lnkd.in/e8VsvVGT

We are thrilled to announce an exciting partnership with BioAgilytix. This collaboration will help customers deliver innovative therapies to patients  by aligning reagent development with assay creation. The partnership will integrate BBI’s ability to efficiently produce high-quality custom antibody reagents for a variety of testing applications, with BioAgilytix’s renowned bioanalytical testing services. This approach simplifies a crucial step in bioanalytical testing for pharma and biopharma sponsors. The more streamlined service will help bring your innovative therapies one step closer to market. Read the full press release: https://bit.ly/3UNKfz1

Big thanks to everyone who stopped by our booth at #WRIB San Antonio! 🌵 ☀ In case you missed us, click the link to talk about teaming up with the experts at MBS in creating successful strategies for developing antibodies for your application that improves assay performance, reduces cost, and shortens timelines. 👉 https://bit.ly/3whV0jv #WRIB #antibodies

#WRIB day 1 is underway! Stop by booth #7 to chat with our experts about your antibody development needs and how a thorough development process can achieve your antibody goals to get the most value out of your antibody strategy. 👉 https://bit.ly/3whV0jv #WRIB #antibodies #AntibodyDevelopment

We are thrilled to announce an exciting partnership with BioAgilytix. This collaboration will help customers deliver innovative therapies to patients  by aligning reagent development with assay creation. The partnership will integrate BBI’s ability to efficiently produce high-quality custom antibody reagents for a variety of testing applications, with BioAgilytix’s renowned bioanalytical testing services. This approach simplifies a crucial step in bioanalytical testing for pharma and biopharma sponsors. The more streamlined service will help bring your innovative therapies one step closer to market. Read the full press release: https://bit.ly/3UNKfz1

We are excited to return to the 18th annual #WRIB conference in San Antonio, TX, next week! Stop by booth #7 to chat with our experts and discuss how we will create successful strategies for developing antibodies for your application that improves assay performance, reduces cost, and shortens timelines. 👉 Click the link to book a meeting on site to learn more about our custom antibody production for your unique application! https://bit.ly/3whV0jv #WRIB #antibodies #AntibodyDevelopment